"Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: Results from the FUTURE 2 study" by Iain B. McInnes

Article

Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: Results from the FUTURE 2 study

Arthritis Research & Therapy (2018)

Iain B. McInnes, University of Glasgow
Philip J. Mease, University of Washington
Georg Schett, University of Erlangen-Nuremberg
Bruce Kirkham, Guy's and St Thomas' NHS Foundation Trust
Vibeke Strand, Stanford University
Nicole Williams, Durham University
Todd Fox, Novartis
Luminita Pricop, Novartis
Steffen M. Jugl, Novartis
Kunal K. Gandhi, Novartis

Link

Disciplines

Physical Therapy,
Medicine and Health Sciences,
Rheumatology,
Internal Medicine and
Immunology and Infectious Disease

Publication Date

December 1, 2018

DOI

10.1186/s13075-018-1610-3

Citation Information

Iain B. McInnes, Philip J. Mease, Georg Schett, Bruce Kirkham, et al.. "Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: Results from the FUTURE 2 study" Arthritis Research & Therapy Vol. 20 Iss. 1 (2018) p. 113
Available at: http://works.bepress.com/philip-mease/318/